Courtesy of U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment


National Resources


SAMHSA

Addiction is a chronic, treatable illness. General principles of good care for chronic diseases can guide OUD treatment. Patients with OUD should have access to mental health services as needed, medical care, and addiction counseling, as well as recovery support services, to supplement treatment with medication. The words you use to describe OUD and an individual with OUD are powerful. For more information visit SAMHSA TIP 63: Medications for Opioid Use Disorder Treatment.

More SAMHSA resources:

National Institute on Drug Abuse

Centers for Disease Control

Department of Health and Human Services

National Council for Behavioral Health

Institute for Research, Education and Training in Addictions

US Food and Drug Administration
Intended for those involved with direct patient care, the FDA’s “Opioid Analgesic Risk Evaluation and Mitigation Strategies (REMS) Education Blueprint for Health Care Providers Involved in the Treatment and Monitoring of Patients with Pain” will allow them to provide evidence-based pain management to their patients on a daily basis. The activity will also provide tools to help clinicians mitigate issues associated with opioid therapies, i.e. misuse and addiction, and take steps to avert the opioid addiction crisis.

At the conclusion of this activity, participants should be able to:

  • Define components of an effective treatment plan, such as treatment goals, patient engagement, and collaboration within the healthcare team

  • Asses the risks and benefits of non-pharmacologic therapies prior to initiating long-term pharmacologic therapy

  • Identify patients who are candidates for treatment with nonopioid pharmacologic analgesics

  • Evaluate criteria for initiating opioid analgesic

  • Identify risk factors for addiction to opioid analgesics

Click here to access the course: https://www.rockpointe.com/courses/opioid-analgesics-risk-evaluation-and-mitigation-strategy-rems-and-the-new-fda-blueprint/


Florida Resources

DCF.png

isaveflthumbnail.jpg

Sponsored by Florida Alliance for Healthy Communities, Inc. and the State of Florida, Department of Children and Families